My Top 3 Favorite Clinical-Stage Biotech Stocks to Buy
These biotech upstarts have deep pockets and late-stage pipelines that could make them savvy buys.
A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.
Key Data Points
Primary metrics and data points about Arena Pharmaceuticals.| Current Price: | $42.68 |
| Prev Close: | $43.58 |
| Open: | $43.57 |
| Bid: | $42.75 |
| Ask: | $44.87 |
| Day's Range: | $42.49 - $43.98 |
| 52wk Range: | $30.00 - $50.05 |
| Volume: | 634,736 |
| Avg Vol | 563,456 |
| Market Cap: | $2B |
| P/E (ttm): | -16.45 |
| EPS (ttm): | -$2.65 |
| Div & Yield: | $0.00 (0.0%) |
Company Rating
What our community thinks about Arena Pharmaceuticals.
CAPS Rating
CAPS All Stars
Powered by 
CEO Rating
The single most important factor in a company's success is the team that's leading the company.Amit Munshi, CEO
94% Approve
Based on 9 Ratings
Business Summary
Industry, sector and description for Arena Pharmaceuticals.A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Drug Makers